InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
54,483.30
(
0.57%
)
Post# of 253058
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 838
Posts 120392
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 35943

Friday, 10/20/2006 6:27:35 PM

Friday, October 20, 2006 6:27:35 PM

Post# of 253058
Addendum re SGP and HCV acquisitions:

Although Hassan did not mention HCV acquisitions, specifically, during today’s CC, he evidently did in an interview later in the day.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061020:MTFH90654_2...

>>
"Our cash flow is going very nicely, which allows us to be more opportunistic, move faster and look at interesting deals," Hassan said in an interview. He said he was particularly keen on acquiring new products to treat cancer, hepatitis C and inflammation.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up